Prosonix has established its pre-eminent position as a world leader in pharmaceutical particle engineering through internal research and development expertise and strategic collaboration with academic and commercial partners, including:
Sterling Spa (Italy)
Sonic Systems Ltd (UK)
Imperial College London (National Heart and Lung Institute)